Trials / Withdrawn
WithdrawnNCT01441531
Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension
Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension During Orif of Tibia Fracture Under General Anesthesia
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Baylor College of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to find out if taking a dose of gabapentin 600 mg by mouth (po) before surgery will help prevent the development of tourniquet pain and hypertension while the tourniquet is inflated during orif of tibia fracture.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gabapentin 600 mg po | Given one hour before surgery |
| DRUG | Placebo pill given one hour before surgery | Placebo pill given |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2011-09-27
- Last updated
- 2015-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01441531. Inclusion in this directory is not an endorsement.